CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)Status:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [TSID12347]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC